Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis.
BACKGROUND AND AIMS: Cumulative safety and tolerability of budesonide MMX(®), a once-daily oral corticosteroid for inducing mild to moderate ulcerative colitis remission, was examined. METHODS: Data from three randomized, double-blind, placebo-controlled, phase II or III studies (budesonide MMX 9 mg...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2015
|